SCHEMBL24021481

SCHEMBL24021481

C=C(/C=C/CN(C)C)Nc1ccc(C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.46
▸ TGM2 P21980 1/20 0.42
▸ PIP4K2A P48426 1/20 0.42
▸ PIP4K2B P78356 1/20 0.42
▸ RAB9A P51151 5/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ NMT1 P30419 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ MMP1 P03956 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ DDAH1 O94760 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351667 0.86 KDM4E (0.45) TGM2PIP4K2APIP4K2BRAB9ANPC1
SCHEMBL23336395 0.83 PIP4K2A (0.36) PIP4K2APIP4K2BSMN1; SMN2KMT2AEGFR
SCHEMBL16665103 0.82 NMT1 (0.58) POLBTGM2PIP4K2APIP4K2BRAB9A
SCHEMBL18722598 0.74 TGM2 (0.50) POLBTGM2RAB9ANPC1KMT2A
SCHEMBL21781161 0.70 TGM2 (0.46) POLBTGM2RAB9ANPC1KMT2A
SCHEMBL23997975 0.70 KDM4E (0.36) —
SCHEMBL13389249 0.70 EGFR (0.55) TGM2PIP4K2APIP4K2BRAB9ANPC1
SCHEMBL10057892 0.69 TDP1 (0.60) POLBTGM2RAB9ANPC1SMN1; SMN2
SCHEMBL27291660 0.69 TAAR1 (0.39) POLBTGM2RAB9ANPC1SMN1; SMN2
SCHEMBL20764166 0.69 CDK14 (0.47) PIP4K2APIP4K2BRAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544970-B1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES THEREOF DANA FARBER CANCER INST INC (US) 2021-11-17 — — EP disclosed
Send feedback